BACKGROUND: Prostaglandin D2 (PGD2) is released from mast cells during the allergic response. OBJECTIVE: Since PGD2 has been shown to induce nasal congestion in humans, we investigated the distribution of hematopoietic prostaglandin D synthase (PGDS) and the two PGD2 receptors, DP and CRTH2 in human nasal mucosa from healthy subjects and subjects suffering from polyposis, a severe form of chronic rhinosinusitis. METHODS: DP mRNA expression was detected by in situ hybridization while PGDS, CRTH2 and various leukocyte markers expression were revealed by immunohistochemistry. RESULTS: In the normal mucosa, PGDS was only detected in few resident mast cells while CRTH2 was undetectable. In contrast, DP receptor mRNA was detected in epithelial goblet cells, serous glands and in the vasculature. In the nasal mucosa of subjects suffering from polyposis: (1) PGDS was detected in mast cells and other large infiltrating inflammatory cells, (2) both DP mRNA and CRTH2 were detected in eosinophils and (3) CRTH2 was detected on a subset of infiltrating T cells. Although DP mRNA could not be detected in the T cells invading the nasal mucosa, it was found to be expressed in the T cells present in the lymph node and the thymus from normal individuals. CONCLUSION: This study indicates that cells capable of producing PGD2 are present in the nasal mucosa and that both PGD2 receptors, DP and CRTH2, might play a role in inflammatory disease of the upper airways.
BACKGROUND:Prostaglandin D2 (PGD2) is released from mast cells during the allergic response. OBJECTIVE: Since PGD2 has been shown to induce nasal congestion in humans, we investigated the distribution of hematopoietic prostaglandin D synthase (PGDS) and the two PGD2 receptors, DP and CRTH2 in human nasal mucosa from healthy subjects and subjects suffering from polyposis, a severe form of chronic rhinosinusitis. METHODS: DP mRNA expression was detected by in situ hybridization while PGDS, CRTH2 and various leukocyte markers expression were revealed by immunohistochemistry. RESULTS: In the normal mucosa, PGDS was only detected in few resident mast cells while CRTH2 was undetectable. In contrast, DP receptor mRNA was detected in epithelial goblet cells, serous glands and in the vasculature. In the nasal mucosa of subjects suffering from polyposis: (1) PGDS was detected in mast cells and other large infiltrating inflammatory cells, (2) both DP mRNA and CRTH2 were detected in eosinophils and (3) CRTH2 was detected on a subset of infiltrating T cells. Although DP mRNA could not be detected in the T cells invading the nasal mucosa, it was found to be expressed in the T cells present in the lymph node and the thymus from normal individuals. CONCLUSION: This study indicates that cells capable of producing PGD2 are present in the nasal mucosa and that both PGD2 receptors, DP and CRTH2, might play a role in inflammatory disease of the upper airways.
Authors: A Van Hecken; M Depré; I De Lepeleire; C Thach; M Oeyen; J Van Effen; T Laethem; K Mazina; T Crumley; L Wenning; K M Gottesdiener; P Deutsch; P Clement; E Lai; J N de Hoon Journal: Eur J Clin Pharmacol Date: 2007-01-03 Impact factor: 2.953
Authors: Tatiana Luna-Gomes; Kelly G Magalhães; Fabio P Mesquita-Santos; Ilka Bakker-Abreu; Rafaela F Samico; Raphael Molinaro; Andrea S Calheiros; Bruno L Diaz; Patrícia T Bozza; Peter F Weller; Christianne Bandeira-Melo Journal: J Immunol Date: 2011-11-18 Impact factor: 5.422
Authors: Chris P Carron; John I Trujillo; Kirk L Olson; Wei Huang; Bruce C Hamper; Tom Dice; Bradley E Neal; Matthew J Pelc; Jacqueline E Day; Douglas C Rohrer; James R Kiefer; Joseph B Moon; Barbara A Schweitzer; Tanisha D Blake; Steve R Turner; Rhonda Woerndle; Brenda L Case; Christine P Bono; Vickie M Dilworth; Christie L Funckes-Shippy; Becky L Hood; Gina M Jerome; Christine M Kornmeier; Melissa R Radabaugh; Melanie L Williams; Michael S Davies; Craig D Wegner; Dean J Welsch; William M Abraham; Chad J Warren; Martin E Dowty; Fengmei Hua; Anup Zutshi; Jerry Z Yang; Atli Thorarensen Journal: ACS Med Chem Lett Date: 2010-02-02 Impact factor: 4.345
Authors: M Eguchi; S Kariya; M Okano; T Higaki; S Makihara; T Fujiwara; K Nagata; H Hirai; S Narumiya; M Nakamura; K Nishizaki Journal: Clin Exp Immunol Date: 2010-12-16 Impact factor: 4.330
Authors: Merritt L Fajt; Stacy L Gelhaus; Bruce Freeman; Crystal E Uvalle; John B Trudeau; Fernando Holguin; Sally E Wenzel Journal: J Allergy Clin Immunol Date: 2013-03-16 Impact factor: 10.793